NIDA supports state-of-the-art genetic/genomic and epigenetic research in the basic, clinical and population sciences of drug addiction. Elucidation of genetic factors, their interactions with behavioral, social, and physical environments, and their relationship to specific phenotypes and associated outcomes including HIV/AIDS, are critical to determining addiction vulnerabilities, and will ultimately help facilitate diagnosis, treatment, and prevention. Read more...
Jonathan D. Pollock, Ph.D.
Chair, NIDA Genetics Workgroup
6001 Executive Drive, RM 4274
Bethesda, MD 20892
Tel. 301-435-1309
Fax. 301-594-6043